Filing Details
- Accession Number:
- 0001599298-23-000103
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-12-13 17:11:56
- Reporting Period:
- 2023-12-11
- Accepted Time:
- 2023-12-13 17:11:56
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1599298 | Summit Therapeutics Inc. | SMMT | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1507650 | Mahkam Zanganeh | C/O Summit Therapeutics Inc. 2882 Sand Hill Road, Suite 106 Menlo Park CA 94025 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-12-11 | 489,814 | $1.44 | 489,814 | No | 4 | X | Direct | |
| Common Stock | Acquisiton | 2023-12-12 | 5,000 | $2.07 | 494,814 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2023-12-11 | 315,681 | $1.58 | 24,889,479 | No | 4 | X | Indirect | By the Mahkam Zanganeh Revocable Trust, with the Reporting Person as Trustee |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | X | Direct | |
| No | 4 | P | Direct | |
| No | 4 | X | Indirect | By the Mahkam Zanganeh Revocable Trust, with the Reporting Person as Trustee |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Warrant (right to buy) | Disposition | 2023-12-11 | 489,814 | $0.00 | 489,814 | $1.44 |
| Common Stock | Warrant (right to buy) | Disposition | 2023-12-11 | 315,681 | $0.00 | 315,681 | $1.58 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2023-12-11 | 2025-06-30 | No | 4 | X | Direct |
| 0 | 2023-12-11 | 2029-12-24 | No | 4 | X | Indirect |
Footnotes
- The Reporting Person exercised certain warrants to purchase shares of common stock in accordance with the terms of such warrants.
- The Reporting Person purchased these shares in a single transaction on the open market.
- The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
Billionaire Hedge Funds
